Subscribe to RSS
Download PDF
DOI: 10.1055/a-2113-2892
Associations between Anemia and Outcomes of Pregnant Patients with Pyelonephritis
Funding This research was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number TL1TR002555. This funding provided Dr. Federspiel's effort for this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Data acquisition was also supported by funding from the Foundation for Women and Girls with Blood Disorders to J.J.F.
Abstract
Objective This study aims to determine if pregnant patients with both pyelonephritis and anemia are at an increased risk of adverse maternal outcomes compared with those with pyelonephritis without anemia.
Study Design We conducted a retrospective cohort study utilizing the Nationwide Readmissions Database (NRD). Patients with antepartum pyelonephritis-associated hospitalizations from October 2015 to December 2018 were included. International Classification of Diseases codes were used to identify pyelonephritis, anemia, maternal comorbidities, and severe maternal morbidities. The primary outcome was a composite of severe maternal morbidity, as defined by the Centers for Disease Control criteria. Univariate statistical methods, weighted to account for complex survey methods in the NRD, were used to assess for associations between anemia, baseline characteristics, and patient outcomes. Weighted logistic and Poisson regressions were used to assess for associations between anemia and outcomes, adjusting for clinical comorbidities and other confounding factors.
Results In total, 29,296 pyelonephritis admissions were identified, corresponding to a weighted national estimate of 55,135 admissions. Of these, 11,798 (21.3%) were anemic. The rate of severe maternal morbidity was higher among anemic patients than nonanemic patients (27.8 vs. 8.9%, respectively, p < 0.001), and remained higher after adjustment (adjusted relative risk [aRR] 2.86 [95% confidence interval [CI]: 2.67, 3.06]). Rates of individual components of severe maternal morbidities, including acute respiratory distress syndrome (4.0 vs. 0.6%, aRR 3.97 [95% CI: 3.10, 5.08]), sepsis (22.5 vs. 7.9%, aRR 2.64 [95% CI: 2.45, 2.85]), shock (4.5 vs. 0.6%, aRR 5.48 [95% CI: 4.32, 6.95]), and acute renal failure (2.9 vs. 0.8%, aRR 1.99 [95% CI: 1.55, 2.55]) were all higher for anemic pyelonephritis. The mean length of stay was also longer (25% average increase, 95% CI: 22, 28%).
Conclusion Among pregnant patients with pyelonephritis, those with anemia are at greater risk of severe maternal morbidity and longer hospital stay.
Key Points
-
Anemia is associated with longer stays for pyelo.
-
Anemic pyelo patients have increased morbidity.
-
Anemic pyelo patients have increased sepsis risk.
Publication History
Received: 13 December 2021
Accepted: 19 June 2023
Accepted Manuscript online:
20 June 2023
Article published online:
20 July 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.
-
References
- 1 Gilstrap III LC, Cunningham FG, Whalley PJ. Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol 1981; 57 (04) 409-413
- 2 Hill JB, Sheffield JS, McIntire DD, Wendel Jr GD. Acute pyelonephritis in pregnancy. Obstet Gynecol 2005; 105 (01) 18-23
- 3 Sharma P, Thapa L. Acute pyelonephritis in pregnancy: a retrospective study. Aust N Z J Obstet Gynaecol 2007; 47 (04) 313-315
- 4 Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol 2014; 210 (03) 219.e1-219.e6
- 5 Cavenee MR, Cox SM, Mason R, Cunningham FG. Erythropoietin in pregnancies complicated by pyelonephritis. Obstet Gynecol 1994; 84 (02) 252-254
- 6 Cox SM, Shelburne P, Mason R, Guss S, Cunningham FG. Mechanisms of hemolysis and anemia associated with acute antepartum pyelonephritis. Am J Obstet Gynecol 1991; 164 (02) 587-590
- 7 (HCUP). HCaUP. HCUP Nationwide 238Readmissions Database (NRS). In: Agency for Healthcare Research and Quality ed. Rockville, MD; 2017
- 8 Leonard SA, Kennedy CJ, Carmichael SL, Lyell DJ, Main EK. An expanded obstetric comorbidity scoring system for predicting severe maternal morbidity. Obstet Gynecol 2020; 136 (03) 440-449
- 9 Prevention CfDCa. Severe Maternal Morbidity in the United States. In: Centers for Disease Control and Prevention, Division of Reproductive Health; 2020
- 10 Austin PC. Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model. J Clin Epidemiol 2010; 63 (01) 2-6
- 11 Dawkins JC, Fletcher HM, Rattray CA, Reid M, Gordon-Strachan G. Acute pyelonephritis in pregnancy: a retrospective descriptive hospital based-study. ISRN Obstet Gynecol 2012; 2012: 519321
- 12 Grette K, Cassity S, Holliday N, Rimawi BH. Acute pyelonephritis during pregnancy: a systematic review of the aetiology, timing, and reported adverse perinatal risks during pregnancy. J Obstet Gynaecol 2020; 40 (06) 739-748
- 13 Dotters-Katz SK, Grotegut CA, Heine RP. The effects of anemia on pregnancy outcome in patients with pyelonephritis. Infect Dis Obstet Gynecol 2013; 2013: 780960
- 14 Turck M, Ronald AR, Petersdorf RG. Relapse and reinfection in chronic bacteriuria. II. The correlation between site of infection and pattern of recurrence in chronic bacteriuria. N Engl J Med 1968; 278 (08) 422-427
- 15 Fairley KF, Bond AG, Adey FD. The site of infection in pregnancy bacteriuria. Lancet 1966; 1 (7444): 939-941